About the company
Global Pharma, a wholly owned subsidiary of Dubai Investments PJSC, was registered in 1998. The company commenced operations in the UAE in 2003 and expanded its reach in 2008 by launching new products in 14 GCC countries, including those in Africa.
Global Pharma has two accelerators to supply pharmaceuticals to the Middle East region: one for manufacturing beta-lactam penicillin to produce amoxicillin and amoxiclav, and another for manufacturing generic drugs. This allows for the development of various dosage forms and formulations to meet the needs of patients with chronic inflammatory conditions.
